UNCY EV/EBITDA
-1.55
+0.06+3.73%
Thu, 23 Jan 2025 00:30:50 GMT
Summary:
As of January 23, 2025, UNCY EV/EBITDA is -1.55, with a rise of +0.06 (+3.73%) during the most recent trading day. Over the past year, it has dropped by -0.83 (-115.28%). UNCY EV/EBITDA is now -274.16% below its all-time high of 0.89.UNCY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UNCY EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +3.7% |
| 1 m1 month | +15.3% |
| 3 m3 months | -198.1% |
| 6 m6 months | -745.8% |
| ytdytd | +32.3% |
| 1 y1 year | -115.3% |
| 5 y5 years | - |
UNCY EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.51 | -2.6% | -2.39 | +35.1% |
| 3 m | 3-month | -0.33 | -369.7% | -2.41 | +35.7% |
| 6 m | 6-month | 0.86 | -280.2% | -2.41 | +35.7% |
| 1 y | 1-year | 0.89 | -274.2% | -2.41 | +35.7% |
| 3 y | 3-year | 0.89 | -274.2% | -2.41 | +35.7% |
| 5 y | 5-year | 0.89 | -274.2% | -31.38 | +95.1% |
| alltime | all time | 0.89 | -274.2% | -31.38 | +95.1% |
Unicycive Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.55(-32.3%) |
| 2024 | -2.29(+218.1%) |
| Date | Value |
|---|---|
| 2023 | -0.72(+63.6%) |
| 2022 | -0.44(-71.8%) |
| 2021 | -1.56 |
FAQ
- What is Unicycive Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Unicycive Therapeutics?
- What is UNCY EV/EBITDA year-to-date change?
- What is Unicycive Therapeutics EV/EBITDA year-on-year change?
What is Unicycive Therapeutics EV/EBITDA?
The current EV/EBITDA of UNCY is -1.55
What is the all time high EV/EBITDA for Unicycive Therapeutics?
Unicycive Therapeutics all-time high EV/EBITDA is 0.89
What is UNCY EV/EBITDA year-to-date change?
Unicycive Therapeutics EV/EBITDA has changed by +0.74 (+32.31%) since the beginning of the year
What is Unicycive Therapeutics EV/EBITDA year-on-year change?
Over the past year, UNCY EV/EBITDA has changed by -0.83 (-115.28%)